Amgen and Astellas Pharma US agree to settlement costs for kickback charges

18:21 EDT 2 May 2019 | European Pharmaceutical Review

Amgen and Astellas Pharma US have agreed to pay a total of $124.75 million to settle allegations that they paid kickbacks to Medicare copays for their own medications.

The post Amgen and Astellas Pharma US agree to settlement costs for kickback charges appeared first on European Pharmaceutical Review.

More From BioPortfolio on "Amgen and Astellas Pharma US agree to settlement costs for kickback charges"